Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic hepatitis]

H Denk1

  • 1Institut für Pathologie, Universität Graz.

Verhandlungen Der Deutschen Gesellschaft Fur Pathologie
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Chronic hepatitis, a liver inflammation lasting over six months, has diverse causes. A new classification system is needed, moving beyond morphology to include etiology, inflammation grading, and disease staging for better understanding and treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Gerhard Korb : 9 February 1929-24 December 2017].

Der Pathologe·2018
Same author

Cytoskeleton-modulation in growth and development.

Cytotechnology·2012
Same author

Mammary intraepithelial neoplasia: a logical concept?

The breast journal·2011
Same author

[Histopathological diagnose of non-alcoholic and alcoholic fatty liver disease].

Zeitschrift fur Gastroenterologie·2010
Same author

[Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Grade 2 consensus-based guidelines].

Der Pathologe·2010
Same author

SAHA induces caspase-independent, autophagic cell death of endometrial stromal sarcoma cells by influencing the mTOR pathway.

The Journal of pathology·2008
Same journal

[The PEA-15 protein induces resistance against glucose deprivation-induced cell death via the ERK/MAP kinase pathway].

Verhandlungen der Deutschen Gesellschaft fur Pathologie·2008
Same journal

[Methylation status of LINE-1 sequences in patients with MDS or secondary AML].

Verhandlungen der Deutschen Gesellschaft fur Pathologie·2008
Same journal

[Heat shock protein 90 alpha und beta are overexpressed in multiple myeloma cells and critically contribute to survival].

Verhandlungen der Deutschen Gesellschaft fur Pathologie·2008
Same journal

[Gastrin cell hyperplasia associated with duodenal MEN1-related gastrinomas: histopathology and genetics].

Verhandlungen der Deutschen Gesellschaft fur Pathologie·2008
Same journal

Artificial intelligence and bladder cancer arrays.

Verhandlungen der Deutschen Gesellschaft fur Pathologie·2008
Same journal

[Mapping of a deletion interval on 8p21-22 in prostate cancer by gene dosage PCR].

Verhandlungen der Deutschen Gesellschaft fur Pathologie·2008
See all related articles

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Context:

  • Chronic hepatitis is defined as necroinflammatory liver disease persisting for at least six months.
  • Etiologies are diverse, including viral infections, autoimmune processes, drug reactions, and metabolic disorders, with some cases remaining cryptogenic.
  • Current classification based on morphology is outdated due to advances in understanding etiology, pathogenesis, and therapy.

Purpose:

  • To propose a modern classification system for chronic hepatitis.
  • The new system should be easy to apply, reproducible, and based on etiology, grading of necroinflammation, and staging of disease.
  • To facilitate comparison of clinical trial results through semi-quantification of histological alterations.

Summary:

  • A modern classification of chronic hepatitis is proposed, integrating etiological factors, grading of necroinflammation (portal, periportal, lobular), and staging of disease (fibrosis, cirrhosis).

Related Experiment Videos

  • This approach moves beyond the traditional morphology-based classification.
  • Histological alterations should be semi-quantified to enhance reproducibility and facilitate clinical trial data comparison.

    • Impact:

    • A revised classification will improve the diagnosis and management of chronic hepatitis.
    • Standardized grading and staging will aid in predicting disease progression and treatment response.
    • Facilitates better clinical trial design and interpretation, advancing therapeutic strategies for chronic liver diseases.